InMed Pharmaceuticals (INM) Net Margin (QoQ) (2022 - 2025)
InMed Pharmaceuticals (INM) Net Margin (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | InMed Pharmaceuticals | 6.56 Mn | 1.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9,312.00 |
| Sep 30, 2025 | -5,404.00 |
| Jun 30, 2025 | -9,586.00 |
| Mar 31, 2025 | 22,736.00 |
| Dec 31, 2024 | -9,895.00 |
| Sep 30, 2024 | 1,779.00 |
| Jun 30, 2024 | -354.00 |
| Mar 31, 2024 | -2,774.00 |
| Dec 31, 2023 | 16,210.00 |
| Sep 30, 2023 | -26,672.00 |
| Jun 30, 2023 | 17,853.00 |
| Mar 31, 2023 | 25,351.00 |
| Dec 31, 2022 | 64,764.00 |
| Sep 30, 2022 | 43,464.00 |
| Jun 30, 2022 | -94,960.00 |
| Mar 31, 2022 | 103,632.00 |